Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Signaling Through Nucleic Acid Sensors and Their Roles in Inflammatory Diseases
Haruna Okude, Daisuke Ori, Taro Kawai
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Fumarate induces vesicular release of mtDNA to drive innate immunity
Vincent Zecchini, Vincent Paupe, Irene Herranz-Montoya, et al.
Nature (2023) Vol. 615, Iss. 7952, pp. 499-506
Open Access | Times Cited: 183
Inflammation and DNA damage: cause, effect or both
Antonio Pezone, Fabiola Olivieri, Maria Vittoria Napoli, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 4, pp. 200-211
Closed Access | Times Cited: 104
Decoding Toll-like receptors: Recent insights and perspectives in innate immunity
Taro Kawai, Moe Ikegawa, Daisuke Ori, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 649-673
Open Access | Times Cited: 100
RNA‐based medicine: from molecular mechanisms to therapy
Anke Sparmann, Jörg Vogel
The EMBO Journal (2023) Vol. 42, Iss. 21
Open Access | Times Cited: 58
The immunostimulatory nature of mRNA lipid nanoparticles
Preeti Sharma, Daniek Hoorn, Anjaiah Aitha, et al.
Advanced Drug Delivery Reviews (2024) Vol. 205, pp. 115175-115175
Open Access | Times Cited: 45
The Epigenetic Hallmarks of Cancer
Manel Esteller, Mark A. Dawson, Cigall Kadoch, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1783-1809
Closed Access | Times Cited: 19
Amphiphilic Block Copolymer Nanostructures as a Tunable Delivery Platform: Perspective and Framework for the Future Drug Product Development
Gaurav Sinsinbar, Anivind Kaur Bindra, Shaoqiong Liu, et al.
Biomacromolecules (2024) Vol. 25, Iss. 2, pp. 541-563
Closed Access | Times Cited: 17
Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants
Guang Han Ong, Benedict Shi Xiang Lian, Takumi Kawasaki, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 62
Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants
Carola G. Vinuesa, Nan Shen, Thuvaraka Ware
Nature Reviews Nephrology (2023) Vol. 19, Iss. 9, pp. 558-572
Closed Access | Times Cited: 39
Moonlighting chromatin: when DNA escapes nuclear control
Jeeshan Singh, Michael Boettcher, Maximilian Dölling, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 4, pp. 861-875
Open Access | Times Cited: 31
Understanding nucleic acid sensing and its therapeutic applications
Ling-Zu Kong, Seok‐min Kim, Chunli Wang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2320-2331
Open Access | Times Cited: 29
IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment
Irina Elcheva, Chethana P. Gowda, Daniel Bogush, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Breaking down the cellular responses to type I interferon neurotoxicity in the brain
Barney Viengkhou, Markus J. Hofer
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Methotrexate suppresses psoriatic skin inflammation by inhibiting muropeptide transporter SLC46A2 activity
Ravi Bharadwaj, Christina F. Lusi, Siavash Mashayekh, et al.
Immunity (2023) Vol. 56, Iss. 5, pp. 998-1012.e8
Open Access | Times Cited: 24
Z-DNA binding protein 1 orchestrates innate immunity and inflammatory cell death
Qixiang Song, Yuhang Fan, Huali Zhang, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 77, pp. 15-29
Closed Access | Times Cited: 11
RNA-based therapies in liver metabolic diseases
Antonio Fontanellas, Pedro Berraondo, F Urigo, et al.
Gut (2025), pp. gutjnl-331742
Open Access | Times Cited: 1
ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery
Miguel Hueso, Adrián Mallén, Marc Suñé-Pou, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11596-11596
Open Access | Times Cited: 48
Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system
Rebecca Anne Bekker, Sungjune Kim, Shari Pilon‐Thomas, et al.
Neoplasia (2022) Vol. 28, pp. 100796-100796
Open Access | Times Cited: 38
Discovery of an inhibitor of DNA-driven inflammation that preferentially targets the AIM2 inflammasome
Jack Green, Lina Y. El‐Sharkawy, S. Roth, et al.
iScience (2023) Vol. 26, Iss. 5, pp. 106758-106758
Open Access | Times Cited: 21
Secretion of mitochondrial DNA via exosomes promotes inflammation in Behçet's syndrome
Hachiro Konaka, Yasuhiro Kato, Tôru Hirano, et al.
The EMBO Journal (2023) Vol. 42, Iss. 20
Open Access | Times Cited: 18
Intrinsic STING Switches off Pathogenetic Programs of Th1 Cells to Inhibit Colitis
Wenjing Yang, Tianming Yu, Guangxi Zhou, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 5, pp. 1161-1179
Open Access | Times Cited: 15
Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4
Meng Yuan, Linghang Peng, Deli Huang, et al.
Structure (2024) Vol. 32, Iss. 6, pp. 766-779.e7
Open Access | Times Cited: 5
Diversification of molecular pattern recognition in bacterial NLR-like proteins
Nathalie Béchon, Nitzan Tal, Avigail Stokar-Avihail, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases
Jun Liu, Hui Zhang, Yanhong Su, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Role of TLRs in HIV-1 Infection and Potential of TLR Agonists in HIV-1 Vaccine Development and Treatment Strategies
Marija Rozman, Snježana Židovec Lepej, Karlo Jambrosic, et al.
Pathogens (2023) Vol. 12, Iss. 1, pp. 92-92
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top